Ionut-Gabriel Funingana (Ionut G Funingana, Ionat-Gabriel Funingana)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 11

Top Topics

Radiation Therapy

Top Venues

Seminars in immunopathology

Nature communications

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Ionut-Gabriel Funingana, Jacob S Bedia, Ying-Wen Huang, Antonio Delgado Gonzalez, Kenyi Donoso, Veronica D Gonzalez, James D Brenton, Alan Ashworth, Wendy J Fantl
Multiparameter single-cell proteomic technologies give new insights into the biology of ovarian tumors. Seminars in immunopathology 45 (1) (2023)
Ionut-Gabriel Funingana, Jacob S Bedia, Ying-Wen Huang, Antonio Delgado Gonzalez, Kenyi Donoso, Veronica D Gonzalez, James D Brenton, Alan Ashworth, Wendy J Fantl
Multiparameter single-cell proteomic technologies give new insights into the biology of ovarian tumors. Seminars in immunopathology 45 (1) (2023)
Philip S Smith, Thomas Bradley, Lena Morrill Gavarró, Teodora Goranova, Darren P Ennis, Hasan B Mirza, Dilrini De Silva, Anna M Piskorz, Carolin Margarethe Sauer, Sarwah Al-Khalidi, Ionut-Gabriel Funingana, Marika A V Reinius, Gaia Giannone, Liz-Anne Lewsley, Jamie Stobo, John McQueen, Gareth Bryson, Matthew D Eldridge, null null, Geoffrey Macintyre, Florian Markowetz, James D Brenton, Iain A McNeish
Author Correction: The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma. Nature communications 14 (1) (2023)
Ionut-Gabriel Funingana, Jacob S Bedia, Ying-Wen Huang, Antonio Delgado Gonzalez, Kenyi Donoso, Veronica D Gonzalez, James D Brenton, Alan Ashworth, Wendy J Fantl
Multiparameter single-cell proteomic technologies give new insights into the biology of ovarian tumors. Seminars in immunopathology 45 (1) (2023)
Philip S Smith, Thomas Bradley, Lena Morrill Gavarró, Teodora Goranova, Darren P Ennis, Hasan B Mirza, Dilrini De Silva, Anna M Piskorz, Carolin Margarethe Sauer, Sarwah Al-Khalidi, Ionut-Gabriel Funingana, Marika A V Reinius, Gaia Giannone, Liz-Anne Lewsley, Jamie Stobo, John McQueen, Gareth Bryson, Matthew D Eldridge, null null, Geoffrey Macintyre, Florian Markowetz, James D Brenton, Iain A McNeish
The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma. Nature communications 14 (1) (2023)
James F Spicer, Bristi Basu, Ana Montes, Udai Banerji, Rebecca S Kristeleit, Rowan E Miller, Gareth J Veal, Christopher J Corrigan, Stephen J Till, Alessandro Massimo Gianni, Silvana Canevari, Claire Barton, Paul Jones, Sarah Mellor, Simon Carroll, Chris Selkirk, George Nintos, Vineet Kwatra, Ionut-Gabriel Funingana, Gary J Doherty, Hannah J Gould, Giulia Pellizzari, Mano Nakamura, Kristina M Ilieva, Atousa Khiabany, Chara Stavraka, Jitesh Chauhan, Cheryl Gillett, Sarah E Pinder, Heather J Bax, Debra H Josephs, Sophia N Karagiannis
Safety and anti-tumour activity of the IgE antibody MOv18 in patients with advanced solid tumours expressing folate receptor-alpha: a phase I trial. Nature communications 14 (1) (2023)
Ionut-Gabriel Funingana, Jacob S Bedia, Ying-Wen Huang, Antonio Delgado Gonzalez, Kenyi Donoso, Veronica D Gonzalez, James D Brenton, Alan Ashworth, Wendy J Fantl
Multiparameter single-cell proteomic technologies give new insights into the biology of ovarian tumors. Seminars in immunopathology 45 (1) (2023)
Ionut-Gabriel Funingana, Jacob S Bedia, Ying-Wen Huang, Antonio Delgado Gonzalez, Kenyi Donoso, Veronica D Gonzalez, James D Brenton, Alan Ashworth, Wendy J Fantl
Multiparameter single-cell proteomic technologies give new insights into the biology of ovarian tumors. Seminars in immunopathology 45 (1) (2023)
Ionut-Gabriel Funingana, Jacob S Bedia, Ying-Wen Huang, Antonio Delgado Gonzalez, Kenyi Donoso, Veronica D Gonzalez, James D Brenton, Alan Ashworth, Wendy J Fantl
Multiparameter single-cell proteomic technologies give new insights into the biology of ovarian tumors. Seminars in immunopathology (2023)
Susana Banerjee, Vasiliki Michalarea, Joo Ern Ang, Alvaro H Ingles Garces, Andrea Biondo, Ionut-Gabriel Funingana, Martin Little, Ruth Ruddle, Florence I Raynaud, Ruth Riisnaes, Bora Gurel, Sue Chua, Nina Tunariu, Joanna C Porter, Toby Prout, Mona Parmar, Anna Zachariou, Alison Turner, Ben Jenkins, Stuart McIntosh, Ed Ainscow, Anna R Minchom, Juanita Lopez, Johann S de Bono, Robert Jones, Emma C Hall, Natalie Cook, Bristi Basu, Udai Banerji
A Phase I Trial of CT900, a Novel α-Folate Receptor-Mediated Thymidylate Synthase Inhibitor, in Patients with Solid Tumors with Expansion Cohorts in Patients with High-Grade Serous Ovarian Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (21) (2022)
Filipe Correia Martins, Dominique-Laurent Couturier, Ines de Santiago, Carolin Margarethe Sauer, Maria Vias, Mihaela Angelova, Deborah Sanders, Anna Piskorz, James Hall, Karen Hosking, Anumithra Amirthanayagam, Sabina Cosulich, Larissa S Carnevalli, Barry R Davies, Thomas B K Watkins, Ionut-Gabriel Funingana, Helen Bolton, Krishnayan Haldar, John Latimer, Peter Baldwin, Robin Crawford, Matthew D Eldridge, Bristi Basu, Mercedes Jimenez-Linan, Andrew W Mcpherson, Nicholas McGranahan, Kevin Litchfield, Sohrab P Shah, Iain A McNeish, Carlos Caldas, Gerard I Evan, Charles Swanton, James D Brenton
Clonal somatic copy number altered driver events inform drug sensitivity in high-grade serous ovarian cancer. Nature communications 13 (1) (2022)